A Randomized, Multicenter, Open-label, Active-controlled, Single-dose, 5-period, Incomplete Block, Cross-over Study to Evaluate the Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort pMDI or Oxis Turbuhaler to Adults With Stable Asthma
Sponsor study identifier
Secondary identifiers
interventional
175
0 countries
N/A
Study Start
October 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
May 2003
Actual (reported)The purpose of this study is to compare the therapeutic effects of formoterol in Symbicort with formoterol in Oxis Turbuhaler for the treatment of adults with stable asthma.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2003
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2002
Date type not reportedThis date has not been verified as actual or estimated.
May 2003
Actual (reported)April 1, 2008
Actual (reported)April 14, 2008
Actual (reported)Average FEV1 during 12 hours
Once a week for 5 weeks during treatment period
Urine levels of formoterol in 2 different formulations
Once a week (12 hour urine collection) for 5 weeks during treatment period
Safety profiles of formoterol in 2 different formulations
Once a week for 5 weeks during treatment period
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
budesonide/formoterol
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordMichael E Ruff, MD
Pharmaceutical Research & Consulting Inc
Catherine Bonuccelli
AstraZeneca
First Submitted
April 1, 2008
First Posted
April 14, 2008
Study Start
October 2002
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
May 2003
Actual (reported)Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5
Contact the study team to confirm eligibility.
Last Updated
January 24, 2011
Record last verified: 2011-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: